Editors' ChoiceCancer Immunotherapy

Exploiting human Tregs’ sweet tooth to improve cancer immunotherapy

See allHide authors and affiliations

Science Translational Medicine  07 Nov 2018:
Vol. 10, Issue 466, eaav6058
DOI: 10.1126/scitranslmed.aav6058


TLR8 activation enhances cancer immunotherapy by reprograming of glucose metabolism in regulatory T cells.

View Full Text

Stay Connected to Science Translational Medicine